1 false false false false false false false false false false true false false false false false false No description of principal activity 2022-03-02 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 13950394 2022-03-02 2023-01-31 13950394 2023-01-31 13950394 2022-03-01 13950394 bus:Director1 2022-03-02 2023-01-31 13950394 core:WithinOneYear 2023-01-31 13950394 core:ShareCapital 2023-01-31 13950394 core:RetainedEarningsAccumulatedLosses 2023-01-31 13950394 bus:SmallEntities 2022-03-02 2023-01-31 13950394 bus:AuditExemptWithAccountantsReport 2022-03-02 2023-01-31 13950394 bus:SmallCompaniesRegimeForAccounts 2022-03-02 2023-01-31 13950394 bus:PrivateLimitedCompanyLtd 2022-03-02 2023-01-31 13950394 bus:FullAccounts 2022-03-02 2023-01-31 13950394 core:AllAssociates 2022-03-02 2023-01-31
COMPANY REGISTRATION NUMBER: 13950394
SS UK Medical Services Ltd
Filleted Unaudited Financial Statements
31 January 2023
SS UK Medical Services Ltd
Statement of Financial Position
31 January 2023
31 Jan 23
Note
£
Current assets
Debtors
5
100,026
Cash at bank and in hand
100
---------
100,126
Creditors: amounts falling due within one year
6
34,263
---------
Net current assets
65,863
--------
Total assets less current liabilities
65,863
--------
Capital and reserves
Called up share capital
100
Profit and loss account
65,763
--------
Shareholders funds
65,863
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 31 January 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 22 January 2024 , and are signed on behalf of the board by:
Dr S Swamy
Director
Company registration number: 13950394
SS UK Medical Services Ltd
Notes to the Financial Statements
Period from 2 March 2022 to 31 January 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Pound Paddock, Church Hill, Kingsnorth, Ashford, Kent, TN23 3EG, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable services rendered, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the period amounted to 1 .
5. Debtors
31 Jan 23
£
Other debtors
100,026
---------
6. Creditors: amounts falling due within one year
31 Jan 23
£
Corporation tax
15,426
Other creditors
18,837
--------
34,263
--------
7. Related party transactions
At the period end the company owed Directors £18,837. At the Balance Sheet date the company was owed £100,026 by companies associated by virtue of common directorship.